Ad-IFNg

interferon gamma-encoding adenovirus

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ad-IFNg, covering 2016-08-08 to 2016-08-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Immunotherapy With TIL (Tumor Infiltrating Lymphocytes) in Combination With Intra-tumoral Injections of Interferon Gamma-adenovirus (Ad-IFNg) in Patients With Stage IIIc or Stage IV Metastatic Melanoma (AJCC)(Protocol TIL-Ad-INFg) [Phase 1, Phase 2]

See pricing